Syndax Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Syndax Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-05 | $-0.98 | $-1.11 | 11.7 % |
Jun 2024 | 2024-08-01 | $-0.80 | $-0.91 | 12.1 % |
Mar 2024 | 2024-05-08 | $-0.85 | $-0.98 | 13.3 % |
Dec 2023 | 2024-02-27 | $-1.00 | $-0.99 | -1.01 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-05 | $12.50M | $11.20M | 11.6 % |
Mar 2023 | 2023-05-08 | $0 | $430.00K | -100.0 % |
Dec 2022 | 2023-02-28 | $0 | $370.00K | -100.0 % |
Sep 2022 | 2022-11-03 | $0 | $750.00K | -100.0 % |
Syndax Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 5, 2024 for Q3.
Syndax Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 5, 2024 for Q3 and the Actual EPS was $-0.98, which beat the estimate of $-1.11.
Syndax Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 5, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.